TNF and rheumatoid arthritis: Of note, TNF-α-blocking agents, such as etanercept, induce amelioration of clinical symptoms, laboratory parameters of inflammation, and radiological progression in patients with immune-mediated arthritis, such as RA, JIA, and psoriatic arthritis [29].